Publications by authors named "Anthony Gonçalves"

183Publications

The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017.

Eur J Cancer 2021 Jan 4;145:11-18. Epub 2021 Jan 4.

Institut Paoli Calmettes, SESSTIM UMR1252, Aix Marseille Univ, INSERM, IRD, Marseille, France. Electronic address:

View Article and Find Full Text PDF
January 2021

Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey.

Cancers (Basel) 2020 Nov 20;12(11). Epub 2020 Nov 20.

APHM, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Equipe CANBIOS Labellisée Ligue Contre le Cancer, Hop Timone, BioSTIC, Biostatistique et Technologies de l'Information et de la Communication, Aix Marseille Univ, 13005 Marseille, France.

View Article and Find Full Text PDF
November 2020

[PARP inhibitors in breast cancer: Current clinical development and perspectives].

Bull Cancer 2020 Oct 28;107(10):1024-1041. Epub 2020 Sep 28.

Aix-Marseille Université, Institut Paoli-Calmettes, CNRS, département d'Oncologie Médicale, CRCM, Inserm, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address:

View Article and Find Full Text PDF
October 2020

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results.

Curr Opin Oncol 2020 Nov;32(6):585-593

Medical Oncology Department, Institut Paoli-Calmettes, Aix-Marseille University, INSERM, CNRS, CRCM.

View Article and Find Full Text PDF
November 2020

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.

Int J Cancer 2021 Jan 6;148(2):375-384. Epub 2020 Aug 6.

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France.

View Article and Find Full Text PDF
January 2021

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.

Cancers (Basel) 2020 Jun 14;12(6). Epub 2020 Jun 14.

Department of Medical Oncology, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF
June 2020

PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?

Cancers (Basel) 2020 May 27;12(6). Epub 2020 May 27.

Medical Oncology Department, Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF
May 2020